DYAI (Dyadic International Inc.) stock: $0.34, $13.6M market cap, $3.1M cash, $10.5M EV, $15.9M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
The Company develops, manufactures, and commercializes precision-engineered, animal-free recombinant proteins and enzymes for applications in life sciences, food and nutrition, and bio-industrial markets. These products are produced using Dyadic’s proprietary microbial expression platforms, including the C1 and Dapibus™ systems, which enable scalable and cost-effective production of recombinant proteins used in research, diagnostics, cell culture, nutrition, and industrial biotechnology.